2Am society Microbial. Report of the ASM task force on antibiotic resistance. Antimicrob Agents Chemother, 1995, Supplements:1-23.
3Words Health Organization. Who global strategy for containment of antimicrobial resistance. WHO/CDS/CSR/DRS/2001.2 [J].
4National Committee for Clinical Laboratory Standards. Performace standards for antimicrobial susceptibility testing[S] M100-S12Vol. 22 No. 1 January 2002.
5Ohya S,Fukuoka T,Masuda N,et al.Microbiological evaluation of panipenem/betamipron,a new parenterally active carlapenem V.increase in susceptibility of pseudomonas aeruginosa to panipenem in low.amino-acid media.Chemo Therapy,1991,39(S-3):132
6Levy SB.The Challenge of antibiotic resistance[J].Scientific American,1998,278:46-53
7Jones RN,Pfaller MA.Bacterial resistance: A worldwide problem[J].Diagn.Microbiol Infect Dis,1998,31:379-388
8Williams RJ,Ryan MJ.Surveillance of antimicrobial resistance-an international perspective[J].Br Med J,1998,317:651
9Am Society Microbiol.Report of the ASM task force on antibiotic resistance[J].Antimicrob Agents,Chemother,1995,Supplement: 1-23
10World Health Organization.WHO global strategy for containment of antimicrobial resistance.WHO/CDS/CSR/DRS/2001.2[J]
6Pfeifle D,Janas E,Wiedemann B.Role of Penicillin-Binding Proteins in the Initiation of the AmpC β-Lactamase Expression in Enterobacter cloacae[J].Antimicrobal Agents and Chemotherapy,2000,44 (1):169-172.
